Transdiagnostic Sleep and Anxiety Treatment

Completed · Not applicable

Conditions studied: Anxiety Disorders

In brief

Background: Anxiety and insomnia disorders are two of the most common and costly mental health conditions. These disorders are frequently comorbid, but current treatment approaches do not target both. To streamline treatment for these commonly comorbid conditions, a novel, computerized intervention was developed targeting a transdiagnostic factor, safety aids, which are cognitive or behavioral strategies individuals use to cope with distress associated with anxiety or insomnia, that paradoxically exacerbate symptoms. A randomized controlled trial was conducted to determine the acceptability and efficacy of this newly developed intervention. Method: Young adults (N = 61) with elevated anxiety and insomnia symptoms were randomized to receive the anxiety-insomnia intervention or a computerized control condition focused on general physical health behaviors. After the intervention, participants were followed up at one week and one month and completed self-report measures.

Key facts

Study ID

NCT03664310

Run by

Florida State University

People needed

61

Starts

2017-08-01

Expected to finish

2018-05-12

Last updated by the study team

2021-02-01

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• 1 SD above the mean in anxiety and insomnia symptoms
• Interest in improving anxiety and sleep

You may not qualify if…

• Participating in another clinical trial

Where it is running

• Anxiety and Behavioral Health Clinic — Tallahassee, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.